FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2075610483> ?p ?o ?g. }

• W2075610483 endingPage "947" @default.
• W2075610483 startingPage "941" @default.
• W2075610483 abstract "A novel l-nucleoside analog, 2′-fluoro-5-methyl-β-l-arabinofuranosyluracil (l-FMAU), was found to be a potent and selective inhibitor of Epstein-Barr virus (EBV) replication. The decrease in the amount of viral production was concentration dependent with a 90% inhibitory concentration of approximately 5 μM. Upon removal of the drug from treated cells, virus production resumed in 21 days. Metabolism studies indicated that l-FMAU could be converted to its mono-, di- and triphosphate metabolites in both EBV producing and non-producing cells. However, the amount of l-FMAU nucleotides formed was three times larger in EBV producing cells than in EBV non-producing cells. The mechanism of selectivity of l-FMAU against EBV does not appear to be due solely to the preferential phosphorylation of l-FMAU in EBV producing cells. The triphosphate of l-FMAU could not be utilized as a substrate by EBV DNA polymerase or the human DNA polymerases α, β, γ, or δ. Therefore, the incorporation of l-FMAU residues into viral DNA may not be the mechanism of antiviral activity. This compound appears to have a mechanism of action different from that of any other antiherpes virus nucleoside analogs. In addition, l-FMAU has very low cytotoxicity with 50% inhibition of cell growth occurring at a concentration of 1 mM. Given the potent inhibitory activity of this compound against EBV and its inability to be incorporated into cellular DNA, l-FMAU analogs should be explored as a new class of anti-EBV agents." @default.
• W2075610483 created "2016-06-24" @default.
• W2075610483 creator A5000085395 @default.
• W2075610483 creator A5015683860 @default.
• W2075610483 creator A5022222202 @default.
• W2075610483 creator A5032991382 @default.
• W2075610483 creator A5037409604 @default.
• W2075610483 creator A5089956088 @default.
• W2075610483 date "1996-04-01" @default.
• W2075610483 modified "2023-10-04" @default.
• W2075610483 title "Inhibition of Epstein-Barr virus replication by a novel l-nucleoside, 2′-fluoro-5-methyl-β-l-arabinofuranosyluracil" @default.
• W2075610483 cites W1507636017 @default.
• W2075610483 cites W1510860856 @default.
• W2075610483 cites W1526530838 @default.
• W2075610483 cites W1582508691 @default.
• W2075610483 cites W1643349961 @default.
• W2075610483 cites W1970265343 @default.
• W2075610483 cites W2008185754 @default.
• W2075610483 cites W2024382021 @default.
• W2075610483 cites W2028522999 @default.
• W2075610483 cites W2032438721 @default.
• W2075610483 cites W2056499304 @default.
• W2075610483 cites W2057749060 @default.
• W2075610483 cites W2065280709 @default.
• W2075610483 cites W2067167821 @default.
• W2075610483 cites W2103356635 @default.
• W2075610483 cites W2160457064 @default.
• W2075610483 cites W2950946613 @default.
• W2075610483 doi "https://doi.org/10.1016/0006-2952(96)00049-4" @default.
• W2075610483 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8651944" @default.
• W2075610483 hasPublicationYear "1996" @default.
• W2075610483 type Work @default.
• W2075610483 sameAs 2075610483 @default.
• W2075610483 citedByCount "58" @default.
• W2075610483 countsByYear W20756104832012 @default.
• W2075610483 countsByYear W20756104832013 @default.
• W2075610483 countsByYear W20756104832015 @default.
• W2075610483 countsByYear W20756104832016 @default.
• W2075610483 countsByYear W20756104832020 @default.
• W2075610483 countsByYear W20756104832022 @default.
• W2075610483 crossrefType "journal-article" @default.
• W2075610483 hasAuthorship W2075610483A5000085395 @default.
• W2075610483 hasAuthorship W2075610483A5015683860 @default.
• W2075610483 hasAuthorship W2075610483A5022222202 @default.
• W2075610483 hasAuthorship W2075610483A5032991382 @default.
• W2075610483 hasAuthorship W2075610483A5037409604 @default.
• W2075610483 hasAuthorship W2075610483A5089956088 @default.
• W2075610483 hasConcept C104317684 @default.
• W2075610483 hasConcept C109316439 @default.
• W2075610483 hasConcept C140704245 @default.
• W2075610483 hasConcept C153911025 @default.
• W2075610483 hasConcept C159047783 @default.
• W2075610483 hasConcept C202751555 @default.
• W2075610483 hasConcept C2522874641 @default.
• W2075610483 hasConcept C2756471 @default.
• W2075610483 hasConcept C2776120743 @default.
• W2075610483 hasConcept C2776543447 @default.
• W2075610483 hasConcept C2777333352 @default.
• W2075610483 hasConcept C2781375147 @default.
• W2075610483 hasConcept C512185932 @default.
• W2075610483 hasConcept C54355233 @default.
• W2075610483 hasConcept C552990157 @default.
• W2075610483 hasConcept C55493867 @default.
• W2075610483 hasConcept C64241487 @default.
• W2075610483 hasConcept C73573662 @default.
• W2075610483 hasConcept C81885089 @default.
• W2075610483 hasConcept C82381507 @default.
• W2075610483 hasConcept C86803240 @default.
• W2075610483 hasConceptScore W2075610483C104317684 @default.
• W2075610483 hasConceptScore W2075610483C109316439 @default.
• W2075610483 hasConceptScore W2075610483C140704245 @default.
• W2075610483 hasConceptScore W2075610483C153911025 @default.
• W2075610483 hasConceptScore W2075610483C159047783 @default.
• W2075610483 hasConceptScore W2075610483C202751555 @default.
• W2075610483 hasConceptScore W2075610483C2522874641 @default.
• W2075610483 hasConceptScore W2075610483C2756471 @default.
• W2075610483 hasConceptScore W2075610483C2776120743 @default.
• W2075610483 hasConceptScore W2075610483C2776543447 @default.
• W2075610483 hasConceptScore W2075610483C2777333352 @default.
• W2075610483 hasConceptScore W2075610483C2781375147 @default.
• W2075610483 hasConceptScore W2075610483C512185932 @default.
• W2075610483 hasConceptScore W2075610483C54355233 @default.
• W2075610483 hasConceptScore W2075610483C552990157 @default.
• W2075610483 hasConceptScore W2075610483C55493867 @default.
• W2075610483 hasConceptScore W2075610483C64241487 @default.
• W2075610483 hasConceptScore W2075610483C73573662 @default.
• W2075610483 hasConceptScore W2075610483C81885089 @default.
• W2075610483 hasConceptScore W2075610483C82381507 @default.
• W2075610483 hasConceptScore W2075610483C86803240 @default.
• W2075610483 hasIssue "7" @default.
• W2075610483 hasLocation W20756104831 @default.
• W2075610483 hasOpenAccess W2075610483 @default.
• W2075610483 hasPrimaryLocation W20756104831 @default.
• W2075610483 hasRelatedWork W1977078068 @default.
• W2075610483 hasRelatedWork W1983196589 @default.
• W2075610483 hasRelatedWork W2029041146 @default.
• W2075610483 hasRelatedWork W2045895410 @default.
• W2075610483 hasRelatedWork W2049415878 @default.

• next